Cymbalta Claims Too Different For Class Actions, Judge Says
An Indiana federal judge on Monday found that the claims of consumers in two consolidated proposed class actions alleging Eli Lilly & Co. concealed the withdrawal risks of its antidepressant Cymbalta...To view the full article, register now.
Already a subscriber? Click here to view full article